Sato Kazuya

サトウカズヤ | Sato Kazuya

Affiliation and department：
Job title： Assistant Professor

Research field (1)： Hematology and oncology

Research keywords (8)：腫瘍特異抗体 , 樹状細胞 , 微小残存病変 , 白血病 , 熱ショック蛋白 , Minimum Residual Disease , Leukemia , Heat Shock Protein

Research theme for competitive and other funds (2)：

1998 - 熱ショック蛋白を用いた白血病に対する免疫療法
1998 - Immunotherapy using heat shock protein against leukemia cells

MISC (25)：

Junko Jimbo, Kazuya Sato, Takaaki Hosoki, Motohiro Shindo, Katsuya Ikuta, Yoshihiro Torimoto, Yutaka Kohgo. Induction of leukemia-specific antibodies by immunotherapy with leukemia-cell-derived heat shock protein 70. CANCER SCIENCE. 2008. 99. 7. 1427-1434
Katsuya Ikuta, Yoshihiro Torimotoa, Junko Jimbo, Junki Inamura, Takaaki Hosoki, Motohirc Shindo, Kazuya Sato, Hiroyuki Takahashi, Yutaka Kohgo. A novel five-way chromosomal translocation observed in chronic myelogenous leukemia. CANCER GENETICS AND CYTOGENETICS. 2008. 183. 1. 69-71
Yamazaki M, Nakamura K, Mizukami Y, Ii M, Sasajima J, Sugiyama Y, Nishikawa T, Nakano Y, Yanagawa N, Sato K, et al. Yamazaki M, Nakamura K, Mizukami Y, Ii M, Sasajima J, Sugiyama Y, Nishikawa T, Nakano Y, Yanagawa N, Sato K, Maemoto A, Tanno S, Okumura T, Karasaki H, Kono T, Fujiya M, Ashida T, Chung DC, Kohgo Y.Sonic hedgehog derived from human pancreatic cancer ce・・・. Cancer Sci. 2008. 99. 6. 1131-1138
Shindo M, Sato K, Jimbo J, Hosoki T, Ikuta K, Sano A, Nishimura K, Torimoto Y, Kohgo Y. Shindo M, Sato K, Jimbo J, Hosoki T, Ikuta K, Sano A, Nishimura K, Torimoto Y, Kohgo Y. Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia. Rinsho Ketsueki. 2007. 48. 5. 412-417
Yasuyuki Iuchi, Yoshihiro Torimoto, Kazuya Sato, Yasuaki Tamura, Junko Jimbo, Junki Inamura, Motohiro Shindo, Katsuya Ikuta, Kouhei Ohnishi, Yutaka Kohgo. Combined use of dendritic cells enhances specific antileukemia immunity by leukemia cell-derived heat shock protein 70 in a mouse model with minimal residual leukemia cells. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2006. 84. 5. 449-458

ｍore...

Lectures and oral presentations (7)：

A Novel Cytotoxic Mechanism by Leukemia-Specific Antibody in Immunotherapy with Leukemia Cell-Derived Heat Shock Protein 70.
(49th Annual Meeting of the American Society of Hematology (Atlanta) 2007)
Increase of Anti-leukemia Effect of Leukemia cell-derived-HSP70 in a combined use of Dendritic Cells.
(4th International Conference on Heat Shock Proteins in Immune Response (Farmington, CT, USA) 2004)
Combined Use of Dendritic Cells enhances Anti-leukemia Effect of Leukemia cell-derived-HSP70 in a Mouse Model with Minimal Residual Leukemia Cells.
(46th Annual Meeting of the American Society of Hematology (San Diego) 2004)
Novel Immunotherapy using dendritic cell pulsed with heat shock protein preparations against mice with leukemia cells after syngeneic bone marrow transplantation.
(45th Annual Meeting of the American Society of Hematology (San Diego) 2003)
Expression of CD26 and Its Intrinsic Dipeptidyl Peptidase IV (DPPIV) Enzyme Activity Enhances Sensitivity to Apoptosis Mediated by Topoisomerase II Inhibitors.
(44th Annual Meeting of the American Society of Hematology (Philadelphia) 2002)

ｍore...

Education (3)：

- 1992 Asahikawa Medical University
- 1992 Asahikawa Medical University School of Medicine Medical Course
- 1992 Asahikawa Medical College Faculty of Medicine

Professional career (1)：

Doctor (Asahikawa Medical College)

Work history (1)：

2001/04 - 2003/03 Research Fellow in Department of Lymphoma/Myeloma, M.D. Anderson Cancer Center, Houston, TX (2001.4~2003.3)

Association Membership(s) (6)：

日本臨床腫瘍学会 , 日本消化器病学会 , 日本内科学会 , 癌治療学会 , 臨床血液学会 , 日本血液学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page